InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by BRINTNALL JOHN, Directeur Stratégique. Insider active across 1 companies, notably CVRx, Inc.. Cumulatively, 5 reports have been recorded. The latest transaction was disclosed on 22 April 2022 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
€3481,590 shares@ €0.21870.0002% mcap24.6% of flow
Common Stock
SEC:0001415889-22-004253:0·
€5322,550 shares@ €0.20860.0003% mcap100.0% of flow
Common Stock
SEC:0001179110-22-000007·
€5322,550 shares@ €0.20860.0003% mcap37.7% of flow
Common Stock
SEC:0001179110-22-000007:0·
2,242 shares
Common Stock
SEC:0001179110-21-007342:0·
2,242 shares
Common Stock
SEC:0001179110-21-007342·
5 of 5 declarations
About BRINTNALL JOHN
John Brintnall serves as Chief Strategy Officer and Secretary at CVRx, Inc. He is responsible for formulating and executing the company's strategy. CVRx is a medical technology company developing innovative solutions to treat hypertension. Mr. Brintnall's expertise in the healthcare sector allows him to contribute to the strategic direction of the company.
